Navigation Links
Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
Date:1/22/2008

ur simplified, automated solution will allow these time-consuming, complex, and labor-intensive tests to migrate into the routine hospital lab. So physicians will get diagnostic information within hours, instead of days or weeks, and be able to begin treating patients much sooner."

Welcoming this new partnership with Beckman Coulter, Dr. Iognaid O Muircheartaigh, NUI Galway president, praised the work of the researchers leading this initiative. "These leading-edge researchers are addressing some of the most challenging and important issues at the frontier of modern biomedical research -- with the ultimate goal of changing the way patients are diagnosed. The research and technology development collaboration with Beckman Coulter is a strong endorsement from industry of the quality and importance of the research being undertaken at NUI Galway."

"We are excited to partner with Beckman Coulter on this unique initiative," said Dr. Daniel O'Mahony, director, Technology Transfer at NUI Galway. "It underpins our commitment to, and support of, research excellence and exemplifies our stated research strategy: creating an environment that values intellectual property, and promoting technology transfer and commercialization activity among University researchers and industry partners. This collaboration brings together molecular diagnostic expertise at NUI Galway with automated solution expertise at Beckman Coulter that will result in the development of break-through technologies for the diagnosis of a variety of infectious diseases in humans."

Established in 1845 as Queen's College Galway, National University of Ireland, Galway is one of Ireland's foremost centers of academic excellence. With more than 15,000 students, it has a long-established reputation of teaching and research excellence in each of its six colleges -- Arts, Social Sciences and Celtic Studies; Science; Law; Commerce; Engineering and Informatics; Medicine, Nursing and Health Sciences.

<
'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Cumberland Pharmaceuticals Inc. ( CPIX) ... results for a patient preference study evaluating Kristalose ... laxative packaged as a crystalline powder, compared to ... the only prescription-strength laxative available in pre-measured powder ... a recent diagnosis of chronic constipation were administered ...
(Date:12/15/2009)... Pa., Dec. 15 Certified healthcare providers ... of complications from the H1N1 flu virus may ... it, the Department of Health announced today. ... to everyone because approximately 3.2 million doses of ... administered it to individuals in the priority groups. ...
(Date:12/15/2009)... ZURICH, Ill., Dec. 15 Fenwal Inc., ... blood collection, separation, safety and availability, announced today ... granted Fenwal approval to market InterSol ® ... ® solution is a specialized product used ... platelets, a vital blood component used to prevent ...
Breaking Medicine Technology:Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients 2Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Westaim announces 2009 third quarter results 61351 1Westaim announces 2009 third quarter results 61351 2Westaim announces 2009 third quarter results 61351 3Westaim announces 2009 third quarter results 61351 4Physicians Heal Bridge to Nowhere 3B Iraqi Girl With Rare Neuromuscular Disorder Has New Hope 61349 1Physicians Heal Bridge to Nowhere 3B Iraqi Girl With Rare Neuromuscular Disorder Has New Hope 61349 2Physicians Heal Bridge to Nowhere 3B Iraqi Girl With Rare Neuromuscular Disorder Has New Hope 61349 3Physicians Heal Bridge to Nowhere 3B Iraqi Girl With Rare Neuromuscular Disorder Has New Hope 61349 4Physicians Heal Bridge to Nowhere 3B Iraqi Girl With Rare Neuromuscular Disorder Has New Hope 61349 5Governor Rendell Helps to Break Ground for New Childrens Hospital at Penn State Hershey 61347 1Governor Rendell Helps to Break Ground for New Childrens Hospital at Penn State Hershey 61347 2
(Date:12/15/2009)... -- Palo Alto Networks(TM), the network security company, ... PA-4000 Series next-generation firewalls for accurate threat prevention ... and control over applications such as peer-to-peer file ... university with eight facilities on five campuses. The ... number of academic schools and institutions throughout Japan. ...
(Date:12/15/2009)... where all couples of reproductive age were evaluated, Italian ... The number of children born with cystic fibrosis decreases ... mutation carriers increases, a new study finds. , CF ... northeast Italy for many years. Since the 1990s, the ... number of infants born with CF. , Two different ...
(Date:12/15/2009)... promised but not delivered ,, WASHINGTON, Dec. ... Congress to ensure that healthcare reform does not ... of insurance companies in 37 states. ,, Prostate ... of the population and individuals who are identifiable ... men who have a family history of prostate ...
(Date:12/15/2009)... Patient advocate Betsy ... of Congress that, "it doesn,t matter whether there,s a ... without a public option - give government authority over ... fund a new social agenda by shifting billions of ... newly arriving immigrants, and local politicians." ,, ...
(Date:12/15/2009)... Physical activity is known to reduce depression and ... study indicates that this effect stems from an individual,s ... or her ability to achieve certain physical goals. ... Medicine . , "We base our arguments on fatigue ... professor of kinesiology and community health at the University ...
Breaking Medicine News(10 mins):Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:Mastery of physical goals lessens disease-related depression and fatigue 2
... money totaling $30,000,has been announced for the inaugural Mississippi Blues Marathon and,Half-Marathon, scheduled for January 5, 2008. Prize money ... Male Female 1st Place ... 3,000 3rd Place 2,000 ... 1,500 5th Place 1,000 1,000, Wheelchair ...
... LOUIS, Oct. 29 Solae, LLC, today announced that,global ... increase by 12,to 24 percent, depending on the product ... Solae CEO and Chairman Craig Binetti said, "Market ... Fortunately, we,re in a great,position to help our customers ...
... Calif., Oct. 29 Howard A.,McLure, President of ... elected Chairman of the Pharmaceutical Care Management Association,s,(PCMA) ... addition to,becoming the new Board Chairman, Mr. McLure ... a two-day event which features health care leaders,discussing ...
... a two-day symposium Nov. 1-2 on diseases of the aorta, ... died of an aortic dissection four years ago. , The ... held in Mary S. Harkness Auditorium at 333 Cedar Street. ... chief of cardiothoracic surgery at Yale. The summit is open ...
... on the topics of cardiovascular risk in chronic ... and ethnic disparities of kidney disease, and anemia ... the American Society of Nephrology,s 40th Annual Meeting ... policy-centered news briefing on Saturday, November 3. , ...
... it can prevent or shorten the illness , MONDAY, Oct. ... blood may help prevent pneumonia in elderly nursing home residents, ... University looked at 617 people 65 and older in 33 ... those with normal blood zinc concentrations were about 50 percent ...
Other Medicine News:Health News:Solae Announces Global Price Increase for Soy Protein Ingredients 2Health News:CVS Caremark's Howard McLure Elected New PCMA Board Chairman 2Health News:Zinc Helps Elderly Ward Off Pneumonia 2
The Bledsoe Ultimate CI is a sport functional knee brace designed for instabilities of combined ACL and PCL injured knees. Additional knee injuries to the medial collateral ligament along with the cr...
... The Bledsoe Cage is ... designed for instabilities of combined ... Additional knee injuries to the ... the crutiate ligaments can be ...
... post-op care demands the best, the Bledsoe Extender ... to 34" (56 cm to 86 cm) in ... leg circumference, this brace easily fits patients from ... tall, and adapts as the patient progresses. The ...
... The Bledsoe Lever Lock Knee ... quick extension lock of the arthroscopic ... to allow motion for rehabilitation or ... quickly locked "rigidly" in full extension ...
Medicine Products: